ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
ApplyBlast uses AI to match you with the right jobs, tailor your resume and cover letter, and apply automatically so you can land your dream job faster.
© All Rights Reserved. ApplyBlast.com
Volastra Therapeutics
Volastra Therapeutics is seeking a bioinformatics and computational biology scientist to power its discovery and translational engine by analyzing genomic, transcriptomic, and clinical data to identify cancer vulnerabilities and biomarkers.
Headquarters
New York, New York, United States
Company Size
11-50 employees
Founded
2019
Volastra Therapeutics is a clinical-stage biotechnology company based in West Harlem, New York City, dedicated to the discovery and development of oncology therapeutics targeting chromosomal instability (CIN) — a key vulnerability found across a wide range of cancers. The company uses its proprietary CINtech research strategy, combining screening techniques and computational modeling, to identify CIN-specific drug targets through synthetic lethality and immune activation approaches. With the mission of "Short Circuiting Cancer's Chaos," Volastra advances its pipeline from discovery through clinical development and pursues partnerships to bring new treatments to patients.
Crain's New York BusinessHarlem startup raises $30M to advance cancer treatments
Sep 26, 2025
Business WireVolastra Therapeutics Expands Clinical Development Program Following Encouraging KIF18A Inhibitor Data and Appoints New Chief Medical Officer to Lead Clinical Strategy
Jan 7, 2026
BioSpaceVolastra Announces Initial Data from First-in-Human Phase I/II Trial of Novel KIF18A Inhibitor VLS-1488 to be Presented at 2025 ASCO Annual Meeting
May 23, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Volastra Therapeutics.
Right around the average for this role
Business WireVolastra Therapeutics Announces Appointment of David P. Southwell as Chief Executive Officer
May 27, 2025
Computational Biology & Bioinformatics Expert (PhD)
micro1
Computational Biology & Bioinformatics Scientist
ZIFO GmbH
Scientist II, Computational Biology & AI
CRISPR Therapeutics
Scientist in Computational Biology
Eikon Therapeutics
Scientist I � Computational Biology and Bioinformatics��
alleninstitute
Principal Scientist, Translational Computational Biology
Bristol Myers Squibb
